Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$39.24$39.77
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.48% | 37.66% | 0.74% | 11.77% | 19.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.48% | 37.66% | 0.74% | 11.77% | 19.05% |
| Cost of Revenue | 36.19% | 17.12% | 28.12% | 36.04% | 31.81% |
| Gross Profit | -1.88% | 41.72% | -3.75% | 7.19% | 16.78% |
| SG&A Expenses | -11.49% | -8.93% | -7.77% | 0.98% | 23.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 940.89% | 940.58% | -137.12% | -- | 105.99% |
| Total Operating Expenses | 6.30% | 5.12% | 24.74% | 18.31% | 25.63% |
| Operating Income | 2.13% | 70.63% | -18.74% | 4.52% | 11.47% |
| Income Before Tax | -18.66% | 86.39% | 4.85% | -21.11% | 40.68% |
| Income Tax Expenses | -17.53% | 88.97% | 8.57% | -17.29% | 45.74% |
| Earnings from Continuing Operations | -18.98% | 85.68% | 3.89% | -22.10% | 39.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.98% | 85.68% | 3.89% | -22.10% | 39.35% |
| EBIT | 2.13% | 70.63% | -18.74% | 4.52% | 11.47% |
| EBITDA | 1.76% | 64.72% | -16.50% | 8.23% | 16.45% |
| EPS Basic | -18.63% | 85.56% | 3.95% | -21.95% | 39.69% |
| Normalized Basic EPS | 0.91% | 86.27% | -11.02% | 8.69% | 15.12% |
| EPS Diluted | -18.77% | 85.50% | 3.99% | -21.83% | 39.93% |
| Normalized Diluted EPS | 0.75% | 86.29% | -10.95% | 8.82% | 15.32% |
| Average Basic Shares Outstanding | -0.42% | 0.07% | -0.06% | -0.20% | -0.24% |
| Average Diluted Shares Outstanding | -0.25% | 0.05% | -0.14% | -0.31% | -0.42% |
| Dividend Per Share | 2.31% | -- | 9.75% | -- | 12.95% |
| Payout Ratio | -- | -0.40% | -- | 0.46% | -- |